CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Millions		Total	Cumulative Effect Period Of Adoption Adjustment	Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Deficit Cumulative Effect Period Of Adoption Adjustment	Treasury Stock	Accumulated Other Comprehensive Income (Loss)
Balance at Dec. 31, 2020		$ 156.9				$ 216.2	$ (53.4)		$ (5.9)
Balance, shares at Dec. 31, 2020				1,200,000	30,018,502
Net income (loss)		(20.8)					(20.8)
Dividends on preferred stock		(2.6)					(2.6)
Stock-based compensation		1.2				1.2
Stock-based compensation, shares					65,000
Warrants exchanged into common stock					2,279,874
Balance at Dec. 31, 2021		134.7				217.4	(76.8)		(5.9)
Balance, shares at Dec. 31, 2021				1,200,000	32,363,376
Net income (loss)		9.3					9.3
Dividends on preferred stock		(3.0)					(3.0)
Dividends on common stock		(3.7)					(3.7)
Stock-based compensation		2.7				2.7
Stock-based compensation, shares					90,649
Foreign currency translation adjustments		(1.5)								$ (1.5)
Change in fair value of derivative, net of tax		(1.4)								(1.4)
Shares issued for acquisition		2.7				2.7
Shares issued for acquisition shares					212,400
Repurchases of common stock, shares	[1]				(472,182)
Balance at Dec. 31, 2022		139.8				222.8	(74.2)		(5.9)	(2.9)
Balance, shares at Dec. 31, 2022				1,200,000	32,194,243
Net income (loss)		8.9					8.9
Dividends on preferred stock		(3.0)					(3.0)
Dividends on common stock		(7.6)					(7.6)
Impact of adoption of new accounting standard (Note 2)			$ (0.5)					$ (0.5)
Stock-based compensation		4.3				4.3
Stock-based compensation, shares					175,577
Foreign currency translation adjustments		1.6								1.6
Change in fair value of derivative, net of tax		(0.5)								(0.5)
Contingent consideration classified as equity		6.3				6.3
Proceeds from stockholder short-swing profits		0.4				0.4
Balance at Dec. 31, 2023		$ 149.7				$ 233.8	$ (76.4)		$ (5.9)	$ (1.8)
Balance, shares at Dec. 31, 2023				1,200,000	32,369,820

[1] Correction of previously disclosed shares repurchased in 2020, not previously reported as a reduction of common stock shares outstanding. Amount is immaterial to the consolidated financial statements.